NasdaqGM:ATRCMedical Equipment
AtriCure (ATRC) Looks Repriced As Strong Q2 Earnings And Higher Guidance Reset The Story
AtriCure (ATRC) is back in focus after second quarter results showed revenue of US$153.6 million and net income of US$8.96 million, alongside updated 2026 guidance and fresh employee stock offering registrations.
See our latest analysis for AtriCure.
Those second quarter results and fresh 2026 guidance helped shift sentiment around AtriCure, with the stock posting a 43.5% 30 day share price return and a 21.67% 7 day share price return, although the 3 year total shareholder return is still...